Previous 10 | Next 10 |
24/7 Market News news releases related 24/7 Market News news releases and 24/7 Market News press releases from 07/23/20 10:30:16 on US and Canada Markets.
DENVER, Colo., July 23, 2020- Yesterday’s announcement that the U.S. Department of Health and Human Services agreed to purchase up to 600 million doses of COVID-19 vaccine, from Pfizer (NYSE:PFE) and its development partner BioNTech (NASDAQ:BNTX), is the latest example of why biotech cont...
DENVER, Colo., July 23, 2020- Yesterday’s announcement that the U.S. Department of Health and Human Services agreed to purchase up to 600 million doses of COVID-19 vaccine, from Pfizer (NYSE:PFE) and its development partner BioNTech (NASDAQ:BNTX), is the latest example of why biotech cont...
DENVER, Colo., July 23, 2020- Yesterday’s announcement that the U.S. Department of Health and Human Services agreed to purchase up to 600 million doses of COVID-19 vaccine, from Pfizer (NYSE:PFE) and its development partner BioNTech (NASDAQ:BNTX), is the latest example of why biotech cont...
DENVER, Colo., July 16, 2020- Today’s biotech headlines include developments from Emmaus Life Sciences, Inc. (OTCQB:EMMA), AC Immune SA (NASDAQ:ACIU), and Nabriva Therapeutics plc (NASDAQ:NBRV). Emmaus Life Sciences, Inc. (OTCQB:EMMA), a leader in sickle cell disease treatment, announced ...
DENVER, Colo., July 16, 2020- Today’s biotech headlines include developments from Emmaus Life Sciences, Inc. (OTCQB:EMMA), AC Immune SA (NASDAQ:ACIU), and Nabriva Therapeutics plc (NASDAQ:NBRV). Emmaus Life Sciences, Inc. (OTCQB:EMMA), a leader in sickle cell disease treatment, announced ...
DENVER, Colo., July 16, 2020- Today’s biotech headlines include developments from Emmaus Life Sciences, Inc. (OTCQB:EMMA), AC Immune SA (NASDAQ:ACIU), and Nabriva Therapeutics plc (NASDAQ:NBRV). Emmaus Life Sciences, Inc. (OTCQB:EMMA), a leader in sickle cell disease treatment, announced ...
DENVER, Colo., July 16, 2020- Today’s biotech headlines include developments from Emmaus Life Sciences, Inc. (OTCQB:EMMA), AC Immune SA (NASDAQ:ACIU), and Nabriva Therapeutics plc (NASDAQ:NBRV). Emmaus Life Sciences, Inc. (OTCQB:EMMA), a leader in sickle cell disease treatment, announced ...
ANN ARBOR, Mich., – June 5, 2020 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), a leading developer of spider silk based fibers, announces that it has submitted its formal application to list the Company’s common stock on the Nasdaq Capital Marke...
DENVER, Colo., June 5, 2020- Shift4 Payments Inc. (NYSE:FOUR) begins trading today, after pricing its initial public offering at $23 per share last night. The payment-processing tech company’s IPO price is above its projected $19 to $21 per share range, as it expects to raise $345 million...
DENVER, Colo., June 5, 2020- Shift4 Payments Inc. (NYSE:FOUR) begins trading today, after pricing its initial public offering at $23 per share last night. The payment-processing tech company’s IPO price is above its projected $19 to $21 per share range, as it expects to raise $345 million...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
14.55%Change Percent:
Hub Group Inc. Company Name:
HUBG Stock Symbol:
NASDAQ Market:
hubgroup.com Website: